Line Bjerrehave Nielsen , Max Olsson , Ulla Møller Weinreich , Magnus Ekström
{"title":"慢性气流受限、呼吸道症状和生活质量在酒精使用类别中的相关性:一项基于人群的研究","authors":"Line Bjerrehave Nielsen , Max Olsson , Ulla Møller Weinreich , Magnus Ekström","doi":"10.1016/j.rmed.2025.108350","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div>Alcohol use has significant health implications, yet the association between alcohol use and respiratory symptoms remains relatively understudied. This study examines the prevalence of hazardous alcohol use and its associations with breathlessness, chronic cough, and health-related quality of life (HRQoL) and whether these associations with chronic airway limitation (CAL) differ by alcohol use.</div></div><div><h3>Methods</h3><div>Cross-sectional study of the Swedish CArdioPulmonary bioImage Study (SCAPIS) comprising 25,424 aged 50–64. Hazardous alcohol use was defined as an Alcohol Use Disorders Identification Test (AUDIT) score ≥8. CAL was defined as a post-bronchodilator FEV1/FVC ratio <0.7. Breathlessness (mMRC rating ≥2), chronic cough, and HRQoL, measured using the Short Form 12 (SF-12) were assessed through questionnaires. Associations were analysed using multivariable regression models adjusted for smoking, BMI, age, sex, comorbidities, and predicted FEV1/FVC %. In secondary analyses, associations between CAL and outcomes were examined stratified by alcohol use.</div></div><div><h3>Results</h3><div>Hazardous alcohol use was present in 11 % of the analytic sample and in 15 % of those with CAL. Hazardous alcohol use was associated with increased odds of breathlessness (odds ratio [OR] 1.37; [95 % confidence interval] 1.09–1.70) and chronic cough (OR 1.46; 1.32–1.62), and with lower physical and mental HRQoL scores. CAL was more strongly associated with symptoms in participants with hazardous alcohol use than in lower-level users.</div></div><div><h3>Conclusion</h3><div>Hazardous alcohol use was linked to increased breathlessness, chronic cough, and lower HRQoL. Associations between CAL and respiratory symptoms were stronger among individuals with hazardous alcohol use, suggesting a potential interaction.</div></div>","PeriodicalId":21057,"journal":{"name":"Respiratory medicine","volume":"248 ","pages":"Article 108350"},"PeriodicalIF":3.1000,"publicationDate":"2025-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Associations between chronic airflow limitation, respiratory symptoms, and quality of life across alcohol use categories: a population based study\",\"authors\":\"Line Bjerrehave Nielsen , Max Olsson , Ulla Møller Weinreich , Magnus Ekström\",\"doi\":\"10.1016/j.rmed.2025.108350\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Introduction</h3><div>Alcohol use has significant health implications, yet the association between alcohol use and respiratory symptoms remains relatively understudied. This study examines the prevalence of hazardous alcohol use and its associations with breathlessness, chronic cough, and health-related quality of life (HRQoL) and whether these associations with chronic airway limitation (CAL) differ by alcohol use.</div></div><div><h3>Methods</h3><div>Cross-sectional study of the Swedish CArdioPulmonary bioImage Study (SCAPIS) comprising 25,424 aged 50–64. Hazardous alcohol use was defined as an Alcohol Use Disorders Identification Test (AUDIT) score ≥8. CAL was defined as a post-bronchodilator FEV1/FVC ratio <0.7. Breathlessness (mMRC rating ≥2), chronic cough, and HRQoL, measured using the Short Form 12 (SF-12) were assessed through questionnaires. Associations were analysed using multivariable regression models adjusted for smoking, BMI, age, sex, comorbidities, and predicted FEV1/FVC %. In secondary analyses, associations between CAL and outcomes were examined stratified by alcohol use.</div></div><div><h3>Results</h3><div>Hazardous alcohol use was present in 11 % of the analytic sample and in 15 % of those with CAL. Hazardous alcohol use was associated with increased odds of breathlessness (odds ratio [OR] 1.37; [95 % confidence interval] 1.09–1.70) and chronic cough (OR 1.46; 1.32–1.62), and with lower physical and mental HRQoL scores. CAL was more strongly associated with symptoms in participants with hazardous alcohol use than in lower-level users.</div></div><div><h3>Conclusion</h3><div>Hazardous alcohol use was linked to increased breathlessness, chronic cough, and lower HRQoL. Associations between CAL and respiratory symptoms were stronger among individuals with hazardous alcohol use, suggesting a potential interaction.</div></div>\",\"PeriodicalId\":21057,\"journal\":{\"name\":\"Respiratory medicine\",\"volume\":\"248 \",\"pages\":\"Article 108350\"},\"PeriodicalIF\":3.1000,\"publicationDate\":\"2025-09-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Respiratory medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0954611125004135\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Respiratory medicine","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0954611125004135","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
Associations between chronic airflow limitation, respiratory symptoms, and quality of life across alcohol use categories: a population based study
Introduction
Alcohol use has significant health implications, yet the association between alcohol use and respiratory symptoms remains relatively understudied. This study examines the prevalence of hazardous alcohol use and its associations with breathlessness, chronic cough, and health-related quality of life (HRQoL) and whether these associations with chronic airway limitation (CAL) differ by alcohol use.
Methods
Cross-sectional study of the Swedish CArdioPulmonary bioImage Study (SCAPIS) comprising 25,424 aged 50–64. Hazardous alcohol use was defined as an Alcohol Use Disorders Identification Test (AUDIT) score ≥8. CAL was defined as a post-bronchodilator FEV1/FVC ratio <0.7. Breathlessness (mMRC rating ≥2), chronic cough, and HRQoL, measured using the Short Form 12 (SF-12) were assessed through questionnaires. Associations were analysed using multivariable regression models adjusted for smoking, BMI, age, sex, comorbidities, and predicted FEV1/FVC %. In secondary analyses, associations between CAL and outcomes were examined stratified by alcohol use.
Results
Hazardous alcohol use was present in 11 % of the analytic sample and in 15 % of those with CAL. Hazardous alcohol use was associated with increased odds of breathlessness (odds ratio [OR] 1.37; [95 % confidence interval] 1.09–1.70) and chronic cough (OR 1.46; 1.32–1.62), and with lower physical and mental HRQoL scores. CAL was more strongly associated with symptoms in participants with hazardous alcohol use than in lower-level users.
Conclusion
Hazardous alcohol use was linked to increased breathlessness, chronic cough, and lower HRQoL. Associations between CAL and respiratory symptoms were stronger among individuals with hazardous alcohol use, suggesting a potential interaction.
期刊介绍:
Respiratory Medicine is an internationally-renowned journal devoted to the rapid publication of clinically-relevant respiratory medicine research. It combines cutting-edge original research with state-of-the-art reviews dealing with all aspects of respiratory diseases and therapeutic interventions. Topics include adult and paediatric medicine, epidemiology, immunology and cell biology, physiology, occupational disorders, and the role of allergens and pollutants.
Respiratory Medicine is increasingly the journal of choice for publication of phased trial work, commenting on effectiveness, dosage and methods of action.